Insmed Announces CFO Transition; Reaffirms 2026 Revenue Guidance
Chief Financial Officer Sara Bonstein will step down after nearly seven years. The company reaffirmed its 2026 revenue guidance for BRINSUPRI and ARIKAYCE.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed